Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp


Corona Virus and Cancer

Background The world is experiencing an outbreak of a new betacoronavirus known as Severe Acute Respiratory Syndrome Corona Virus 2, SARS-CoV-2 or simply Corona Virus.

Read More »

Kidney cancer – Novel drug shows promise in advanced disease

Published on February 15, 2020 Background Scientists report promising activity of the novel an oral first-in-class MK-6482 drug that targets a key driver of clear

Read More »

A New Targeted Therapy Pill Extends Lives of Patients with Metastatic Renal Cell Carcinoma, RCC

Background In the phase III trial, more than 300 patients with metastatic RCC were randomly chosen to receive Fotivda (Tivozanib) or Nexavar (Sorafenib) for a

Read More »

Faslodex + Capivasertib vs Placebo in Metastatic, ER positive Breast Cancer

Published February 5, 2020 Background Capivasertib (AZD5363) is an oral inhibitor of AKT and by that it influences cell division, apoptosis and cell metabolism. The

Read More »

To get a personal free assessment to our service please in fill in your details and we will get back to you shortly

Improve therapeutic outcomes, prolong life and quality of life are our main business. We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics

Close Menu